NCT04139421 is a NA clinical trial of Shinrin-Yoku in Mental Health Wellness, sponsored by Chinese University of Hong Kong.

Who is sponsoring NCT04139421?

NCT04139421 is sponsored by Chinese University of Hong Kong.

What drugs are being tested in NCT04139421?

Interventions in NCT04139421: Shinrin-Yoku.

What condition does NCT04139421 study?

NCT04139421 studies Mental Health Wellness.

Is NCT04139421 still recruiting?

NCT04139421 is currently status unknown. Last updated 11 March 2020.

Last reviewed 2020-03-11 · How we verify

NCT04139421

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Shinrin-Yoku (Forest Bathing) on Psychological Well-being

Status unknown NA Last updated 11 March 2020

What this trial tests

NA trial testing Shinrin-Yoku in Mental Health Wellness in 30 participants. Status unknown.

Timeline

1 November 2019

Primary endpoint
30 January 2020

30 March 2020

Quick facts

Lead sponsor	Chinese University of Hong Kong
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	30
Start date	1 November 2019
Primary completion	30 January 2020
Estimated completion	30 March 2020
Sites	2 locations across Hong Kong

Drugs / interventions tested

Shinrin-Yoku

Conditions studied

Mental Health Wellness — all drugs for Mental Health Wellness →

Sponsor

Chinese University of Hong Kong

Who can join

Adults 18 to 65, any sex, with Mental Health Wellness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will examine the effects of Shinrin-Yoku (forest bathing) as an intervention for enhancing psychological well-being in Chinese population. The main component of Shinrin-Yoku is the use of 5 senses in various activities, which typically includes forest walking, meditation, yoga etc. While Shinrin-Yoku has been widely recognized in Japan as a means of preventative health and stress management, it is still a new concept in some countries. In the existing literature, there is increasing evidence demonstrating the efficacy of Shinrin-Yoku for improving for health promotion. However, there is very limited research examining the effectiveness of Shinrin-Yoku in different types of natural environment and the sustainability of its effects.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Mental Health Wellness

Currently open trials in the same condition.

NCT06597474 — Food-Body-Mind Intervention (16 Weeks) · Phase 2, PHASE3 · recruiting
NCT05394311 — Testing the Feasibility of a Sports-based Mental Health Promotion Intervention for Adolescents in Nepal · NA · recruiting
NCT05760001 — The IGNITE for Kids Study on Concentrated Investment in Black Neighborhoods and Child Health and Well-Being · NA · active not recruiting
NCT05895604 — The Mother in Norway Study · NA · recruiting
NCT05833555 — Harlem Strong Mental Health Coalition · NA · recruiting

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

NCT07508644 — RSV Vaccination to Reduce Recurrent AECOPD · Phase 4 · not yet recruiting
NCT07230457 — Plasma MTB cfDNA Before Bronchoscopy · not yet recruiting
NCT07288671 — Nostalgia Intervention on Alleviating Loneliness Amongst Older Adults · NA · not yet recruiting
NCT07256457 — Postoperative Pulmonary Function Assessment Based on Deep Learning Study · NA · not yet recruiting
NCT06904209 — Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04139421 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chinese University of Hong Kong
Last refreshed: 11 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04139421.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing